Microbiomes, epigenomics, immune response, and splicing signatures interplay: potential use of combination of regulatory pathways as targets for malignant mesothelioma

HIGHLIGHTS

  • who: Botle Precious Setlai and colleagues from the Department of Surgery, Level, Bridge E, Steve Biko Academic Hospital, Faculty of Health Sciences, University of Pretoria, Private Bag, Pretoria, South Africa have published the research work: Microbiomes, Epigenomics, Immune Response, and Splicing Signatures Interplay: Potential Use of Combination of Regulatory Pathways as Targets for Malignant Mesothelioma, in the Journal: (JOURNAL)
  • how: This review discusses epigenetic mechanisms with more focus on miRNAs and their interaction with the microbiome.

SUMMARY

    Published maps and institutional affil- Malignant mesothelioma (MM) affects the mesothelium cell lining. Malignant . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?